SCHEMBL6371273

SCHEMBL6371273

C[C@H]1CCC=NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1476809 1.00 — —
SCHEMBL10296596 0.86 — —
SCHEMBL22107878 0.82 NOS3 (0.34) —
SCHEMBL11173217 0.71 — —
SCHEMBL17773095 0.67 — —
SCHEMBL16938576 0.67 — —
SCHEMBL4315746 0.67 — —
SCHEMBL5726315 0.67 — —
SCHEMBL4315743 0.67 — —
SCHEMBL11802610 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178333-B2 Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds CODEXIS, INC. (US) 2012-05-15 — — US disclosed
US-20100063300-A1 BIOCATALYTIC PROCESSES FOR THE PREPARATION OF SUBSTANTIALLY STEREOMERICALLY PURE FUSED BICYCLIC PROLINE COMPOUNDS CODEXIS, INC. (US) 2010-03-11 — — US disclosed
Send feedback